The future of Eddie Bauer's extensive North American store network is in jeopardy, with a bankruptcy filing imminent for its operating entity. While e-commerce and wholesale operations have been transferred, the fate of hundreds of physical retail locations hangs in the balance.
Capital Management Corp has partially cashed in on InterDigital's stellar year, selling a portion of its holdings in the wireless tech licensor. The move is seen as prudent portfolio rebalancing rather than a loss of faith in the company's 5G and AI-driven growth story.
Merck & Co. is set to report fourth-quarter 2025 results before the bell on Tuesday, with Wall Street anticipating steady growth. The pharmaceutical giant's shares have climbed 13% over the past year, outpacing the broader healthcare sector. All eyes will be on Keytruda's sales trajectory and management's guidance for the year ahead.
The iconic outdoor apparel brand Eddie Bauer is preparing to file for Chapter 11 bankruptcy and close its physical stores across the U.S. and Canada, marking a decisive shift to a digital-first future while retaining some international retail presence.
As Amgen prepares to report earnings, analysts are divided on the stock's trajectory. While strategic acquisitions and a solid track record fuel optimism, looming competitive pressures and a key pipeline wait temper expectations.
Chinese courts have executed four senior members of a Myanmar-based criminal organization for murder, trafficking, and running a multi-billion dollar scam operation that exploited thousands, including Chinese citizens. The move is part of a broader crackdown on cross-border cyber fraud hubs.
The trial of Marius Borg Høiby, son of Crown Princess Mette-Marit, opens in Oslo, exposing a profound crisis for the Norwegian monarchy as he faces charges including rape and assault.
Political scientist Laura Fernandez Delgado has won Costa Rica's presidency outright in the first round, becoming the nation's second female leader and pledging to deepen the economic policies of the outgoing administration amid challenges of crime and a divided legislature.
A Connecticut man faces charges after police say he operated a snow plow under the influence of cocaine, leading to a destructive path through residential properties on his very first shift.
The century-old outdoor apparel brand, owned by Catalyst Brands, is preparing a Chapter 11 filing that could shutter its North American store network, while its e-commerce and wholesale operations are set for a transfer to new licensee Outdoor 5.
While Viatris shares have edged past the broader market over the past year, analysts maintain a guarded stance, balancing solid fundamentals against recent profitability pressures and a mixed earnings record.
As Baidu pivots from its search engine roots, its heavy investments in autonomous vehicle technology are beginning to yield operational results, reshaping analyst views and sparking fresh valuation discussions amidst fierce AI competition.
Reports of discussions between Ford Motor Company and Chinese tech giant Xiaomi over a potential electric vehicle partnership have ignited industry speculation, despite both firms denying any imminent deal. The talks underscore the complex interplay of technology, geopolitics, and market access shaping the global EV race.
In a bold marketing move, telehealth company Hims & Hers is leveraging the Super Bowl's massive audience to spotlight healthcare inequality with its 'Rich People Live Longer' campaign. The push comes as the company expands into advanced diagnostics and treatments, while its stock navigates a significant valuation gap after recent volatility.
Senator James Lankford's annual oversight report details what he calls wasteful federal spending, including controversial NIH-funded projects on transgender-related animal testing and aborted fetal tissue research, reigniting debates on scientific priorities and fiscal responsibility.
Shares of clinical-stage biotech Scholar Rock (NASDAQ: SRRK) have surged nearly 60% in three months, closing at $44.34. This rally, backed by promising clinical progress, has investors weighing its premium valuation against its long-term potential in treating serious diseases.
Barclays initiates coverage with an Overweight rating and $20 price target on Altimmune, citing strong fundamentals and pipeline potential. The biotech firm prepares to channel recent offering proceeds toward its pivotal Phase 3 development for metabolic liver disease treatment pemvidutide.
Piper Sandler raises its price target on ImmunityBio, citing a near 700% surge in Anktiva sales and promising interim data from the QUILT trials that could support a major label expansion by 2027.
Marius Borg Høiby, son of Crown Princess Mette-Marit, was arrested on new violent charges days before his rape trial, casting a shadow over the monarchy just as his mother faces renewed criticism over her past association with Jeffrey Epstein.
A suspected human smuggler with a prior conviction was shot by federal agents near the Arizona-Mexico border after allegedly firing at a CBP helicopter and agents during a foot pursuit, according to law enforcement officials.
